S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
The 3-Stock Retirement Blueprint (Ad)
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
The 3-Stock Retirement Blueprint (Ad)
MarketBeat: Week in Review 9/26 – 9/30
How major US stock indexes fared Friday 9/30/2022
The 3-Stock Retirement Blueprint (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
West rejects Putin's claim it sabotaged Baltic gas pipelines
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
The 3-Stock Retirement Blueprint (Ad)
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
The 3-Stock Retirement Blueprint (Ad)
MarketBeat: Week in Review 9/26 – 9/30
How major US stock indexes fared Friday 9/30/2022
The 3-Stock Retirement Blueprint (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
West rejects Putin's claim it sabotaged Baltic gas pipelines
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
The 3-Stock Retirement Blueprint (Ad)
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
The 3-Stock Retirement Blueprint (Ad)
MarketBeat: Week in Review 9/26 – 9/30
How major US stock indexes fared Friday 9/30/2022
The 3-Stock Retirement Blueprint (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
West rejects Putin's claim it sabotaged Baltic gas pipelines
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
The 3-Stock Retirement Blueprint (Ad)
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
The 3-Stock Retirement Blueprint (Ad)
MarketBeat: Week in Review 9/26 – 9/30
How major US stock indexes fared Friday 9/30/2022
The 3-Stock Retirement Blueprint (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
West rejects Putin's claim it sabotaged Baltic gas pipelines
NASDAQ:NEPT

Neptune Wellness Solutions - NEPT Stock Forecast, Price & News

$1.52
+0.03 (+2.01%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.45
$1.59
50-Day Range
$1.09
$3.20
52-Week Range
$1.00
$22.35
Volume
42,774 shs
Average Volume
306,577 shs
Market Capitalization
$12.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.25

Neptune Wellness Solutions MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
1,627.0% Upside
$26.25 Price Target
Short Interest
Healthy
4.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.00mentions of Neptune Wellness Solutions in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($4.20) to ($2.33) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.14 out of 5 stars

Medical Sector

554th out of 1,093 stocks

Pharmaceutical Preparations Industry

262nd out of 547 stocks

NEPT stock logo

About Neptune Wellness Solutions (NASDAQ:NEPT) Stock

Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.

Receive NEPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neptune Wellness Solutions and its competitors with MarketBeat's FREE daily newsletter.

NEPT Stock News Headlines

Neptune Wellness to Raise $8M in Private Offering
Neptune Wellness Solutions FQ3 2022 Earnings Preview
See More Headlines
Receive NEPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neptune Wellness Solutions and its competitors with MarketBeat's FREE daily newsletter.

NEPT Company Calendar

Last Earnings
7/08/2022
Today
10/01/2022
Next Earnings (Estimated)
11/21/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NEPT
Employees
58
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$26.25
High Stock Price Forecast
$26.25
Low Stock Price Forecast
$26.25
Forecasted Upside/Downside
+1,627.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-74,970,000.00
Net Margins
-110.52%
Pretax Margin
-131.22%

Debt

Sales & Book Value

Annual Sales
$48.80 million
Book Value
$10.94 per share

Miscellaneous

Free Float
7,938,000
Market Cap
$12.72 million
Optionable
Optionable
Beta
1.88

Key Executives

  • Mr. James S. Hamilton
    Pres, CEO & Director
  • Mr. Mario Paradis
    VP & CFO
  • Mr. Marc Vaugeois
    VP of Sales
  • Mr. Michel Timperio
    Pres of Cannabis Bus.
  • Mr. François-Karl Brouillette
    VP of Science & Innovation of Nutraceutical Bus.













NEPT Stock - Frequently Asked Questions

Should I buy or sell Neptune Wellness Solutions stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NEPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEPT, but not buy additional shares or sell existing shares.
View NEPT analyst ratings
or view top-rated stocks.

What is Neptune Wellness Solutions' stock price forecast for 2022?

2 Wall Street analysts have issued 12-month target prices for Neptune Wellness Solutions' stock. Their NEPT share price forecasts range from $26.25 to $26.25. On average, they predict the company's share price to reach $26.25 in the next year. This suggests a possible upside of 1,627.0% from the stock's current price.
View analysts price targets for NEPT
or view top-rated stocks among Wall Street analysts.

How have NEPT shares performed in 2022?

Neptune Wellness Solutions' stock was trading at $14.35 at the beginning of 2022. Since then, NEPT stock has decreased by 89.4% and is now trading at $1.52.
View the best growth stocks for 2022 here
.

When is Neptune Wellness Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 21st 2022.
View our NEPT earnings forecast
.

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) issued its quarterly earnings data on Friday, July, 8th. The biotechnology company reported ($2.63) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $11.53 million for the quarter. Neptune Wellness Solutions had a negative trailing twelve-month return on equity of 63.89% and a negative net margin of 110.52%.

When did Neptune Wellness Solutions' stock split?

Neptune Wellness Solutions's stock reverse split before market open on Monday, June 13th 2022. The 1-35 reverse split was announced on Monday, June 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Cara Therapeutics (CARA), Innovative Industrial Properties (IIPR), Zynerba Pharmaceuticals (ZYNE), Amarin (AMRN) and NewAge (NBEV).

What is Neptune Wellness Solutions' stock symbol?

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

How do I buy shares of Neptune Wellness Solutions?

Shares of NEPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neptune Wellness Solutions' stock price today?

One share of NEPT stock can currently be purchased for approximately $1.52.

How much money does Neptune Wellness Solutions make?

Neptune Wellness Solutions (NASDAQ:NEPT) has a market capitalization of $12.72 million and generates $48.80 million in revenue each year. The biotechnology company earns $-74,970,000.00 in net income (profit) each year or ($12.2748) on an earnings per share basis.

How can I contact Neptune Wellness Solutions?

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The official website for the company is www.neptunecorp.com. The biotechnology company can be reached via phone at 45-0687-2262, via email at m.paradis@neptunecorp.com, or via fax at 45-0687-2272.

This page (NASDAQ:NEPT) was last updated on 10/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.